跳至主要内容
临床试验/EUCTR2014-003273-42-FR
EUCTR2014-003273-42-FR进行中(未招募)1 期

Comparing a diuretic vascular filling in the initial management of acute pulmonary embolism with right ventricular dysfunction normotensive

CHU de Nice0 个研究点目标入组 0 人开始时间: 2015年6月29日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
CHU de Nice

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • older than 18 Patient
  • Hospitalized in the first 24 hours of a serious EP normotensive formally diagnosed (by a chest CT)
  • The serious nature without hypotension is defined by the presence of:
  • - From biological criteria: troponin and / or BNP positive
  • - In sonographic criteria: dilated right ventricle defined by echocardiography right over left ventricle ratio (VG)> 0.9 in apical 4-chamber or 0.7 in large parasternal axis and right ventricular systolic dysfunction (TAPSE <16 mm and S 'pulsed TDI tricuspid <10 cm / sec) or pulmonary arterial hypertension (PAH) Pulmonary Arterial Pressure with systolic (PAPs)> 35 mmHg or paradoxical septum
  • Informed consent signed
  • Affiliation to social security
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • Thrombolysis before inclusion
  • State of cardiogenic shock defined as systolic BP <90 mmHg or a drop of> 40 mmHg in systolic BP for> 15 minutes
  • severe chronic renal impairment defined by clearance <30 ml / min.
  • pregnant or nursing woman (a pregnancy test will be performed for women of childbearing age and the results will be communicated to the patient by a doctor of his choice)
  • Most People under guardianship
  • hospitalized without their consent and not protected by law No
  • Private person of liberty
  • Residence time of more than 24 hours in another department after the positive diagnosis of pulmonary embolism

研究者

发起方
CHU de Nice

相似试验